Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, Steven S., Patel, Nikunj K., Hotton, Gary R., O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J., Svendsen, Clive N. +1 more·2003·Nature Medicine
DOI 10.1038/nm850

Cited by (1,000)

Items 801–900 of 1,000

  1. A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease
    Eoin Mulroy, Barry J. Snow, Arnold P. L. Bok, Mark Simpson, Andrew Smith, Kenneth M. Taylor, Michelle Marie Lockhart, B.B. Janice Lam, CHRISTOPHER M. A. FRAMPTON, Gregory Finucane et al. · 2020 · Parkinsonism & Related Disorders
  2. Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease
    Kyle Farmer, Chris Rudyk, Natalie A. Prowse, Shawn P. Hayley · 2015 · Frontiers in Aging Neuroscience
  3. Evaluation of pressure‐driven brain infusions in nonhuman primates by intra‐operative 7 tesla MRI
    Kathryn Hammond Rosenbluth, Alastair J. Martin, John Bringas, Krystof S. Bankiewicz · 2012 · Journal of Magnetic Resonance Imaging
  4. Glial cell line-derived neurotrophic factor is crucial for long-term maintenance of the nigrostriatal system
    Nina Nevalainen, Maria Chermenina, Anna Rehnmark, Elisabet Berglöf, Franziska Marschinke, Ingrid Strömberg · 2010 · Neuroscience
  5. Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting
    Grishma N. Pawar, Neha N. Parayath, Aditya Sharma, Carlos Coito, Olga Khorkova, Jane H. Hsiao, William T. Curry, Mansoor M. Amiji, Benjamin Saul Bleier · 2021 · Frontiers in Pharmacology
  6. Neurotrophic Factors and Their Receptors
    1995 · Nature Biotechnology
  7. Can We Teach Old Dogs New Tricks? Neuroprotective Cell Therapy in Alzheimer's and Parkinson's Disease
    Zuzana Kazmerova, Norbert Žilka, Martin Cente, Peter Neradil, Monika Žilková, Michal Novák · 2013 · Journal of Alzheimer s Disease
  8. Cells therapy for Parkinson’s disease—so close and so far away
    Zhenhua Ren, Yu Zhang · 2009 · Science in China Series C Life Sciences
  9. Braving New Worlds: To Conquer, to Endure
    M. Moffat · 2004 · Physical Therapy
  10. Gene therapy in Parkinson?s disease
    Olaf Eberhardt, Jörg Bernhard Schulz · 2004 · Cell and Tissue Research
  11. Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
    NhuanDo Thi, Paulette Saillour, Lucy Ferrero, Tiina Paunio, Jacques J. Mallet · 2006 · Gene Therapy
  12. Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop
    Roger A. Barker, Märt Saarma, Clive Niels Svendsen, Catherine Morgan, Alan L. Whone, Massimo S. Fiandaca, Matthias Luz, Krystof S. Bankiewicz, Brian K. Fiske, Lyndsey Isaacs et al. · 2024 · Journal of Parkinson s Disease
  13. Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches
    Daniel Garzón, Ricardo Cabezas, Nelson E. Vega-Vela, Marco Ávila-Rodriguez, Janneth González, Rosa Margarita Gómez, Valentina Echeverrı́a, Gjumrakch M. Aliev, George Emilio Barreto · 2016 · Journal of Molecular Neuroscience
  14. Improving therapeutic potential of GDNF family ligands
    Pia Runeberg‐Roos, Richard D. Penn · 2020 · Cell and Tissue Research
  15. The Role of Astrocytes in Parkinson’s Disease
    Roger Garcia, Sara M. Zarate, Rahul Srinivasan · 2024 · Advances in neurobiology
  16. Towards Clinical Application of Neurotrophic Factors to the Auditory Nerve; Assessment of Safety and Efficacy by a Systematic Review of Neurotrophic Treatments in Humans
    Aren Bezdjian, Véronique J. C. Kraaijenga, Dyan Ramekers, Huib Versnel, Hans G. X. M. Thomeer, Sjaak F.L. Klis, Wilko Grolman · 2016 · International Journal of Molecular Sciences
  17. Magneto‐Optogenetic Deep‐Brain Multimodal Neurostimulation
    Finlay Walton, Eve McGlynn, Rupam Das, Hongze Zhong, Hadi Heidari, Patrick A Degenaar · 2021 · Advanced Intelligent Systems
  18. A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system
    Eduardo Ansorena, Erkuden Casales, Alejandro Aranda, Esther Tamayo, Elisa Garbayo, Cristian Smerdou, María J. Blanco‐Prieto, Maria S. Aymerich · 2012 · International Journal of Pharmaceutics
  19. Potential Drugs and Methods for Preventing or Delaying the Progression of Huntington's Disease
    Youssef Sari · 2011 · Recent Patents on CNS Drug Discovery
  20. A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency
    Aristides D. Tagalakis, Sara Castellaro, Haiyan Zhou, Alison S. Bienemann, Mustafa M. Munye, David McCarthy, Edward White, Stephen L. Hart · 2015 · International Journal of Nanomedicine
  21. Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques
    Mallory J. Stenslik, April Evans, François Pomerleau, Ryan M. Weeks, Peter F. Huettl, E. Foreman, Jadwiga T. Turchan-Cholewo, Anders H. Andersen, Wayne A. Cass, Z. Zhang et al. · 2018 · Journal of Neuroscience Methods
  22. Potential of gene therapy for pediatric neurotransmitter diseases: Lessons from Parkinson's disease
    Un Jung Kang, Ken Nakamura · 2003 · Annals of Neurology
  23. Present and future directions in the management of motor complications in patients with advanced PD
    C. Warren Olanow · 2003 · Neurology
  24. Gene therapy for Parkinson’s disease using recombinant adeno-associated viral vectors
    S. Muramatsu, H. Tsukada, I. Nakano, K. Ozawa · 2005 · Expert Opinion on Biological Therapy
  25. STN stimulation and neuroprotection in Parkinson's disease--when beautiful theories meet ugly facts
    Peter C. Warnke · 2005 · Journal of Neurology Neurosurgery & Psychiatry
  26. A new approach to disease-modifying drug trials in Parkinson’s disease
    Roger A. Barker, Mark A. Stacy, Patrik Brundin · 2013 · Journal of Clinical Investigation
  27. Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design
    Jorge E. Quintero, John T. Slevin, Julie A. Gurwell, Christopher J. McLouth, Riham H. El Khouli, Monica J. Chau, Zain Guduru, Greg A. Gerhardt, Craig G. van Horne · 2022 · BMJ Neurology Open
  28. Using a Transection Paradigm to Enhance the Repair Mechanisms of an Investigational Human Cell Therapy
    Monica J. Chau, Jorge E. Quintero, Paula V. Monje, S. Randal Voss, Andrew S. Welleford, Greg A. Gerhardt, Craig G. van Horne · 2022 · Cell Transplantation
  29. A burgeoning science of embryological genetics demands a modern ethics
    RG Edwards · 2007 · Reproductive BioMedicine Online
  30. Glial cell-line derived neurotrophic factor is essential for electroconvulsive shock-induced neuroprotection in an animal model of Parkinson's disease
    Agustín Anastasía, José Wojnacki, Gabriel A. de Erausquin, Daniel Hugo Mascó · 2011 · Neuroscience
  31. Psychosurgery – A Historical Perspective
    Carsten Reidies Bjarkam, Jens Christian Hedemann Sørensen · 2009 · Springer eBooks
  32. Glial cell‐line derived neurotrophic factor and neurturin regulate the expressions of distinct miRNA precursors through the activation of GFRα2
    Li Foong Yoong, Guoqiang Wan, Heng‐Phon Too · 2006 · Journal of Neurochemistry
  33. Development of Parkinson’s disease biomarkers
    Kumar Manharlal Prakash, Eng‐King Tan · 2010 · Expert Review of Neurotherapeutics
  34. Inducible regulation of GDNF expression in human neural stem cells
    ShuYan Wang, Ping Ren, Yunqian Guan, Chunlin Zou, Linlin Fu, Y.Alex Zhang · 2012 · Science China Life Sciences
  35. Characterizing Thermal Augmentation of Convection-Enhanced Drug Delivery with the Fiberoptic Microneedle Device
    R. Lyle Hood, Rudy T. Andriani, Tobias Ecker, John L. Robertson, Christopher G. Rylander · 2015 · Engineering
  36. Human Brain Imaging of Dopamine Transporters
    Andrea Varrone, Christer Halldin · 2014 · Elsevier eBooks
  37. Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration
    Susan R. Goulding, Martin Lévesque, Aideen M. Sullivan, Louise Collins, Gerard W. O’Keeffe · 2021 · Molecular Neurobiology
  38. In Vivo Microdialysis in Parkinson’s Research
    Giuseppe Di Giovanni, Ennio Esposito, Vincenzo Di Matteo · 2009 · Springer eBooks
  39. Increased neurotrophic factor levels in ventral mesencephalic cultures do not explain the protective effect of osteopontin and the synthetic 15-mer RGD domain against MPP + toxicity
    Lauren Broom, Peter G. Jenner, Sarah Rose · 2014 · Experimental Neurology
  40. Cell Therapy for Parkinson's Disease: Only Young Onset Patients Allowed? Reflections about the Results of Recent Clinical Trials with Cell Therapy and the Progression of Parkinson's Disease
    Gurutz Linazasoro · 2006 · Cell Transplantation
  41. Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson?s disease
    Deyi Duan, Hui Yang, Jingzhong Zhang, Jinlu Zhang, Qunyuan Xu · 2004 · Experimental Brain Research
  42. Deep brain stimulation and chemical neuromodulation: current use and perspectives for the future
    Clement Hamani, Joseph Samir Neimat, Andrés M. Lozano · 2007 · Springer eBooks
  43. Editorial
    John Howard Sampson, Raghu Raghavan, Martin Brady, Allan H. Friedman, Darell D. Bigner · 2011 · Journal of neurosurgery
  44. Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
    Laura Stahn, Justyna Rasińska, Tilo Dehne, Stefanie Schreyer, Aileen Hakus, Manfred Gossen, Barbara Steiner, Shabnam Hemmati‐Sadeghi · 2023 · Drug Delivery and Translational Research
  45. Can Parkinson’s disease be cured by stimulating neurogenesis?
    Thomas Foltynie · 2015 · Journal of Clinical Investigation
  46. Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway
    Jan Booij, Henk W. Berendse · 2011 · Journal of the Neurological Sciences
  47. Parkinson's disease: Present and future of cell therapy
    Francisco Javier Sancho-Bielsa · 2022 · Neurology Perspectives
  48. Production of highly pure human glycosylated GDNF in a mammalian cell line
    Eduardo Ansorena, Elisa Garbayo, José Luis Lanciego, María S. Aymerich, María J. Blanco‐Prieto · 2009 · International Journal of Pharmaceutics
  49. Neural Fate of Mesenchymal Stem Cells and Neural Crest Stem Cells: Which Ways to Get Neurons for Cell Therapy Purpose?
    Virginie Neirinckx, Cécile Coste, Bernard Rogister, Sabine Wislet‐Gendebien · 2013 · InTech eBooks
  50. Astroglial U87 Cells Protect Neuronal SH-SY5Y Cells from Indirect Effect of Radiation by Reducing DNA Damage and Inhibiting Fas Mediated Apoptotic Pathway in Coculture System
    Yasmeen Saeed, Abdul Rehman, Bingjie Xie, Jin Xu, Hong Ma, Qing Hong, Yulin Deng · 2015 · Neurochemical Research
  51. GFR-α1 Expression in Substantia Nigra Increases Bilaterally Following Unilateral Striatal GDNF in Aged Rats and Attenuates Nigral Tyrosine Hydroxylase Loss Following 6-OHDA Nigrostriatal Lesion
    Ella Anle Kasanga, Catherine L. Owens, Mark A. Cantu, Adam D. Richard, Richard W. Davis, Lisa M. McDivitt, Blake Blancher, Brandon Scott Pruett, Christopher Tan, Austin Gajewski et al. · 2019 · ACS Chemical Neuroscience
  52. NEUROTROPHIC FACTORS
    Eugene M. Johnson, Mark H. Tuszynski · 2008 · Elsevier eBooks
  53. PET imaging of the basal ganglia
    Arto Laihinen, Ulrike Halsband · 2006 · Journal of Physiology-Paris
  54. New developments in diagnosis and treatment of Parkinson?s disease?From basic science to clinical applications
    Alexander Storch, Anne Hofer, Rejko Krüger, Jörg Bernhard Schulz, J�rgen Winkler, Manfred Gerlach · 2004 · Journal of Neurology
  55. Expressions and possible roles of GDNF receptors in the developing dopaminergic neurons
    Jun Ping Cao, Fu Zhen Li, Yuan Yuan Zhu, Hong Yuan, Zheng Yu, Dianshuai Gao · 2010 · Brain Research Bulletin
  56. Fibrin As a Scaffold for Delivery of GDNF Overexpressing Stem Cells to the Adult Rat Brain
    Teresa C. Moloney, Mary Ní Fhlathartaigh, Mangesh Kulkarni, Abhay S. Pandit, Eilís Dowd · 2015 · ACS Biomaterials Science & Engineering
  57. Stem Cell Biology in Health and Disease
    Thomas Dittmar, Kurt S. Zänker · 2009 · Springer eBooks
  58. Gene therapy approaches for the treatment of Parkinson's disease
    B DASS, Jeffrey H. Kordower · 2007 · Handbook of clinical neurology
  59. Current Science of Regenerative Medicine with Stem Cells
    David A. Prentice · 2006 · Journal of Investigative Medicine
  60. Research on Parkinson Disease
    John T. Slevin, Greg A. Gerhardt, Charles D. Smith, Don Marshall Gash, Richard J. Kryscio, Byron A. Young · 2005 · Journal of neurosurgery
  61. Endothelium-targeted delivery of PPARδ by adeno-associated virus serotype 1 ameliorates vascular injury induced by hindlimb ischemia in obese mice
    Yalan Wu, Xiao Lin, Huiling Hong, Yee Lok Fung, Xiaoyun Cao, Joyce Ka Yu Tse, Tsz Ho Li, Ting‐Fung Chan, Xiao Yu Tian · 2022 · Biomedicine & Pharmacotherapy
  62. Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson’s disease
    Guo Ge, Barath Prashanth Sivasubramanian, Bill D. Geng, Shujie Zhao, Qing Zhou, Gang Huang, Jason C. O’Connor, Robert A. Clark, Senlin Li · 2024 · Gene Therapy
  63. Bridging between transplantation therapy and neurotrophic factors in Parkinson s disease
    George M. Smith · 2014 · Frontiers in Bioscience-Elite
  64. Gene therapy for Parkinson’s disease: state-of-the-art treatments for neurodegenerative disease
    Michael R. Douglas · 2013 · Expert Review of Neurotherapeutics
  65. Non-viral human proGDNF gene delivery to rat bone marrow stromal cells under ex vivo conditions
    Ali Noori-Zadeh, Seyed Alireza Mesbah‐Namin, Taki Tiraihi, Masoumeh Rajabibazl, Taher Taheri · 2014 · Journal of the Neurological Sciences
  66. Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
    Jonah Gordon, Gavin Lockard, Molly Monsour, Adam Alayli, Hassan Choudhary, Cesar V. Borlongan · 2022 · International Journal of Molecular Sciences
  67. Neuroprotective Effects of GDNF-expressing Human Amniotic Fluid Cells
    Anna Jezierski, Kerry Rennie, Bogdan Zurakowski, Maria Ribecco‐Lutkiewicz, Julie Haukenfrers, Abdellah Ajji, Andrée Gruslin, Marianna Sikorska, Mahmud Bani‐Yaghoub · 2014 · Stem Cell Reviews and Reports
  68. Decreased face primary motor cortex (face-M1) excitability induced by noxious stimulation of the rat molar tooth pulp is dependent on the functional integrity of face-M1 astrocytes
    L. Awamleh, Henry Pun, Jye‐Chang Lee, Limor Avivi‐Arber · 2015 · Experimental Brain Research
  69. Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line–derived neurotrophic factor in the striatum of the rat
    Birgit Mertens, Ann Massie, Yvette Madeleine Michotte, Sophie Sarre · 2009 · Neuroscience
  70. Human/nonhuman primate AC–PC ratio—Considerations for translational brain measurements
    Massimo S. Fiandaca, Ernesto A. Salegio, Dali Yin, Robert Mark Richardson, Francisco E. Valles, Paul Larson, Philip A. Starr, Russell R. Lonser, Krystof S. Bankiewicz · 2010 · Journal of Neuroscience Methods
  71. Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor
    Eszter Kótyuk, Nóra Németh, Zsolt Rónai, Zsolt Demetrovics, Mária Sasvári‐Székely, Anna Székely · 2016 · Journal of Genetics
  72. Computationally Guided Intracerebral Drug Delivery via Chronically Implanted Microdevices
    Khalil B. Ramadi, Ashvin Bashyam, Chris J. Frangieh, Erin B. Rousseau, Max J. Cotler, Róbert Langer, Ann M. Graybiel, Michael J. Cima · 2020 · Cell Reports
  73. Neuroreplacement, Growth Factor, and Small Molecule Neurotrophic Approaches for Treating Parkinson's Disease
    Michael J. O’Neill, Marcus J. Messenger, Viktor Lakics, Tracey K. Murray, Eric H. Karran, Philip G. Szekeres, Eric S. Nisenbaum, Kalpana Merchant · 2006 · International review of neurobiology
  74. Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
    Massimo S. Fiandaca, Krystof S. Bankiewicz, Howard J. Federoff · 2012 · Pharmaceuticals
  75. Bypassing the blood–brian barrier using established skull base reconstruction techniques
    Marcel M. Miyake, Benjamin Saul Bleier · 2015 · World Journal of Otorhinolaryngology - Head and Neck Surgery
  76. Subthalamic nucleus stimulation in Parkinson's disease
    Alim Louis Benabid, Stéphan Chabardès, Jean François Le Bas · 2009 · Oxford University Press eBooks
  77. Is there a role for MR‐guided focused ultrasound in Parkinson's disease?
    Ying Meng, Mathew Ryan Voisin, Suganth Suppiah, Suneil Kumar Kalia, Lorraine V. Kalia, Clement Hamani, Nir Lipsman · 2018 · Movement Disorders
  78. Is There a Future for Neural Transplantation?
    Timothy Harrower, Roger A. Barker · 2004 · BioDrugs
  79. Peripheral stimulation in treating Parkinson's disease: Is it a realistic idea or a romantic whimsicality?
    Asakawa · 2012 · Intractable & Rare Diseases Research
  80. Nanotechnology in gene delivery for neural regenerative medicine
    Mona Shahlaei, Shaahin Mohammadzadeh Asl, Maryam Saeidifar · 2020 · Elsevier eBooks
  81. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways
    Carla P. Fonseca, Susana Gama, Ana Saavedra, Graça Baltazar · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  82. Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery Systems
    Sarah Jarrin, Abrar Hakami, Ben Newland, Eilís Dowd · 2021 · Journal of Parkinson s Disease
  83. Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
    Laura Serwer, Rintaro Hashizume, Tomoko Ozawa, C. David James · 2010 · Journal of Visualized Experiments
  84. Surgical Management of Tremor
    Jason M. Schwalb, Andrés M. Lozano · 2004 · Neurosurgery Quarterly
  85. Milestones in neuroimaging
    A. Jon Stoessl, David James Brooks, David Eidelberg · 2011 · Movement Disorders
  86. Stem Cell and Gene-Based Therapy
    Alexander Battler, Jonathan Leor · 2006 · Springer eBooks
  87. Survival assay of transiently transfected dopaminergic neurons
    Li-Ying Yu, Urmas Arumäe · 2007 · Journal of Neuroscience Methods
  88. Inhibition of Chromatin Condensation Prevents Transgene Silencing in a Neural Progenitor Cell Line Transplanted to the Rat Brain
    Nina Rosenqvist, Johan Jakobsson, Cecilia Lundberg · 2005 · Cell Transplantation
  89. Functional neurosurgery: past, present, and future.
    Alim‐Louis Benabid, Stéphan Chabardès, Éric Seigneuret, Pierre Pollak, Valérie Fraix, Paul Krack, Lebas Jf, Sylvie Grand, Brigitte Piallat · 2005 · PubMed
  90. Mesencephalic Human Neural Progenitor Cells Transplanted into the Adult Hemiparkinsonian Rat Striatum Lack Dopaminergic Differentiation but Improve Motor Behavior
    Marine Hovakimyan, Stefan Jean-Pierre Haas, Oliver Schmitt, Bernd Gerber, Andreas Wree, Christian Andressen · 2008 · Cells Tissues Organs
  91. Smarcd1 antagonizes the apoptosis of injured MES23.5 DA cells by enhancing the effect of Six2 on GDNF expression
    Jin Gao, Deng-li Qin, Chuanxi Tang, Xiaoyu Kang, Chengjie Song, Can-tang Zhang · 2021 · Neuroscience Letters
  92. The subthalamic nucleus and the placebo effect in Parkinson's disease
    Elisa Frisaldi, Denisa Adina Zamfira, Fabrizio Benedetti · 2021 · Handbook of clinical neurology
  93. BDNF-loaded chitosan-based mimetic mussel polymer conduits for repair of peripheral nerve injury
    Lei Li, Ziyue Chu, Shihao Li, Tong Zheng, Shusheng Wei, Yunpeng Zhao, Peilai Liu, Qunshan Lu · 2024 · Frontiers in Cell and Developmental Biology
  94. Glial Cell Line-Derived Neurotrophic Factor Partially Ameliorates Motor Symptoms without Slowing Neurodegeneration in Mice with Respiratory Chain-Deficient Dopamine Neurons
    Fredrik H. Sterky, Karin Pernold, Brandon K. Harvey, Eva Lindqvist, Barry J. Hoffer, Lars Olson · 2012 · Cell Transplantation
  95. Gene Therapy for Parkinson’s Disease
    Takao Yasuhara, Isao Date · 2009 · Springer eBooks
  96. What is the Most Promising Treatment for Parkinson‘s Disease: Genes, Cells, Growth Factors or None of the Above?
    Gemma A. Cummins, Roger A. Barker · 2012 · Regenerative Medicine
  97. The Pro-Apoptotic Substance Thapsigargin Selectively Stimulates Re-Growth of Brain Capillaries
    Celine Ullrich, Christian Humpel · 2009 · Current Neurovascular Research
  98. Regenerative Medicine for Parkinson’s Disease
    Takao Yasuhara, Masahiro Kameda, Takashi Agari, Isao Date · 2015 · Neurologia medico-chirurgica
  99. Protective and reversal effects of conserved dopamine neurotrophic factor on PC12 cells following 6-hydroxydopamine administration
    Jiaming Mei, Chaoshi Niu · 2012 · Molecular Medicine Reports
  100. Frontiers in the surgical treatment of Parkinson’s disease
    Michael S. Remple, Yaw Sarpong, Joseph Samir Neimat · 2008 · Expert Review of Neurotherapeutics